presents the effectiveness of the electrochemical system developed for optimisation of the FET system shown in the manuscript for discriminating the presence of a single-base mismatched oligo for a prominent ctDNA mutation, KRAS G12D, with regards to the change in voltammetric peak current after target hybridisation. This figure has been included to represent the ability of the electrochemical system used in this study for FET optimisation to detect a single-base mismatch to prove specificity of the system. The figure shows data related to KRAS G12D, however, we believe our sensor would respond equally well to single-base mismatch P53 mutations. Table S1 contains the sequences used for the KRAS G12D study shown in Figure S1 including the mutant DNA probe sequence and the mutant and wildtype DNA target sequences for the oligo sequences tested. Much longer PCR products of these targets were also tested for comparison. Figure S1 shows a clear discrimination between the mutant and wildtype sequence for both the standard oligo and PCR
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